These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

American Conference on Pharmacometrics 2024

Phoenix, Arizona Oct 10 - 13, 2024

Results 2

Abstract | Oct 10, 2024

Revumenib Physiologically Based Pharmacokinetic (PBPK) Model for Evaluation of Age Effect and CYP3A4-mediated Drug-Drug Interaction (DDI) in Relapsed /Refractory Acute Leukemias

Chapron A, et al.

View Material

Abstract | Oct 10, 2024

Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias

Lin YW, et al.

View Material

Link to Third-Party Site

The link you have selected will take you to a separate website not owned or controlled by Syndax Pharmaceuticals, Inc. Syndax does not recommend, endorse, or make any representation regarding the content on any third-party websites.